A Survey of Marine Natural Compounds and Their Derivatives with Anti-Cancer Activity Reported in 2011
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Cancer continues to be a major public health problem despite the efforts that have been made in the search for novel drugs and treatments. The current sources sought for the discovery of new molecules are plants, animals and minerals. During the past decade, the search for anticancer agents of marine origin to fight chemo-resistance has increased greatly. Each year, several novel anticancer molecules are isolated from marine organisms and represent a renewed hope for cancer therapy. The study of structure-function relationships has allowed synthesis of analogues with increased efficacy and less toxicity. In this report, we aim to review 42 compounds of marine origin and their derivatives that were published in 2011 as promising anticancer compounds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Ganesan, P., Noda, K., Manabe, Y., Ohkubo, T., Tanaka, Y., Maoka, T., Sugawara, T., & Hirata, T. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.02.008 · Cited by 187 · cited 1×
“It also induces apoptosis in HL-60 cells through caspase-3 activation, which has been associated with the enhancement of GADD45α and DR5 expression levels as well as the suppression of Bcl-2 expression [114].”
BackgroundCole, K. E., Dowling, D. P., Boone, M. A., Phillips, A. J., & Christianson, D. W. (2011) · Journal of the American Chemical Society · doi:10.1021/ja205972n · Cited by 153
Anti-angiogenic effect of siphonaxanthin from green alga, Codium fragile
Ganesan, P., Matsubara, K., Ohkubo, T., Tanaka, Y., Noda, K., Sugawara, T., & Hirata, T. (2010) · Phytomedicine · doi:10.1016/j.phymed.2010.05.005 · Cited by 112
Zhang, J.-Y., Tao, L.-Y., Liang, Y.-J., Chen, L.-M., Mi, Y.-J., Zheng, L.-S., Wang, F., She, Z.-G., Lin, Y.-C., To, K. K. W., et al. (2010) · Marine Drugs · doi:10.3390/md8041469 · Cited by 103
Ma, D., Zou, B., Cai, G., Hu, X., & Liu, J. O. (2006) · Chemistry – A European Journal · doi:10.1002/chem.200600599 · Cited by 99 · cited 1×
“Several studies of the structure-function relationship of the apratoxin family showed that modification on the configuration at C-2 and C-37 is crucial for potent cytotoxicity whereas modifications at the C33-C43 and C28-C31 chains can reduce the effectiveness of this compound [42–44].”
BackgroundStat3 Orchestrates Tumor Development and Progression: The Achilles Heel of Head and Neck Cancers?
Masuda, M., Wakasaki, T., Suzui, M., Toh, S., Joe, A., & Weinstein, I. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910790980197 · Cited by 60
Cited by
Blunt, J. W., Copp, B. R., Keyzers, R. A., Munro, M. H. G., & Prinsep, M. R. (2015) · Natural Product Reports · doi:10.1039/c4np00144c · Cited by 613
Exploring the ocean for new drug developments: Marine pharmacology
Malve, H. (2016) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.171700 · Cited by 420
Anti-Inflammatory and Anticancer Drugs from Nature
Orlikova, B., Legrand, N., Panning, J., Dicato, M., & Diederich, M. (2014) · Cancer Treatment and Research · doi:10.1007/978-3-642-38007-5_8 · Cited by 108
Self-citationMeng, Z., Li, T., Ma, X., Wang, X., Van Ness, C., Gan, Y., Zhou, H., Tang, J., Lou, G., Wang, Y., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0314 · Cited by 97
Sawadogo, W., Boly, R., Cerella, C., Teiten, M., Dicato, M., & Diederich, M. (2015) · Molecules · doi:10.3390/molecules20047097 · Cited by 49
Metadata
- Authors
- Sawadogo, W., Schumacher, M., Teiten, M.-H., Cerella, C., Dicato, M., & Diederich, M.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2013-03-25
- Volume
- 18
- Issue
- 4
- Pages
- 3641-3673
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2081079409
- Cited by
- 96
- References
- 9
- FWCI
- 13.31
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.